A gene therapy has been used to treat Huntington's disease, with reports suggesting it may be the first successful treatment of the disease. The therapy appears to have slowed the progression of the disease, with some outlets citing a specific percentage decrease, although the extent of the slowdown is not universally agreed upon. The treatment was administered in a trial in the UK, marking a potential breakthrough in the fight against the disease.